← All indications
Papillomavirus Vaccines
Vaccines or candidate vaccines used to prevent PAPILLOMAVIRUS INFECTIONS. Human vaccines are intended to reduce the incidence of UTERINE CERVICAL NEOPLASMS, so they are sometimes considered a type of CANCER VACCINES. They are often composed of CAPSID PROTEINS, especially L1 protein, from various types of ALPHAPAPILLOMAVIRUS.
Subtype terms (1)
More specific conditions that are subtypes of Papillomavirus Vaccines in the MeSH hierarchy.
- Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
3 drugs (2 approved, 1 experimental)
Drugs by status
Phase 4 trials (3)
Phase 3 trials (1)
Phase 2 trials (1)